Filter Results:
- Full text PDF available (55)
Publication Year
1976
2019
- This year (35)
- Last 5 years (122)
- Last 10 years (236)
Publication Type
Co-author
Journals and Conferences
Learn More
- Robert C. Smallridge, Kenneth B. Ain, +10 authors Robert Michael Tuttle
- Thyroid : official journal of the American…
- 2012
BACKGROUND
Anaplastic thyroid cancer (ATC) is a rare but highly lethal form of thyroid cancer. Rapid evaluation and establishment of treatment goals are imperative for optimum patient management and… (More)
- Chandrakanth Are, Ashok R. Shaha
- Annals of Surgical Oncology
- 2006
Anaplastic thyroid carcinoma (ATC) is one of the most aggressive solid tumors known to affect humans and carries a dismal prognosis. Our primary aim was to review its epidemiology, biology, risk… (More)
- Alexander Stojadinovic, Ashok R. Shaha, +7 authors Dennis H. Kraus
- Annals of surgery
- 2002
OBJECTIVE
To analyze voice function before and after thyroidectomy for patients with normal preoperative voice using a standardized multidimensional voice assessment protocol.
SUMMARY BACKGROUND… (More)
- Allen S Ho, Evan E Sarti, +10 authors Luc G T Morris
- Thyroid : official journal of the American…
- 2014
BACKGROUND
The Bethesda System for Reporting Thyroid Cytopathology is the standard for interpreting fine needle aspiration (FNA) specimens. The "atypia of undetermined significance/follicular lesion… (More)
- Xavier León, Alfio Ferlito, +7 authors Alessandra Rinaldo
- Acta oto-laryngologica
- 2002
- Kepal Narendra Patel, Ashok R. Shaha
- Cancer control : journal of the Moffitt Cancer…
- 2006
BACKGROUND
Poorly differentiated thyroid carcinoma (PDTC) and anaplastic (undifferentiated) thyroid carcinoma (ATC) comprise a small subset of thyroid tumors that are associated with a poor prognosis… (More)
Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis.
- Christopher J. Hughes, Ashok R. Shaha, Jatin P Shah, Thom R. Loree
- Head & neck
- 1996
BACKGROUND
Cervical lymph node metastasis in differentiated thyroid carcinoma has mostly been found to have little relationship to prognosis. However, some studies report nodal involvement to be an… (More)
- David G. Pfister, Yungpo Bernard Su, +9 authors Michael J Zelefsky
- Journal of clinical oncology : official journal…
- 2006
PURPOSE
Cetuximab is a chimeric monoclonal antibody that targets the epidermal growth factor receptor. Cetuximab has activity in squamous cell carcinoma and enhances both chemotherapy and… (More)
BACKGROUND
American Thyroid Association guidelines currently recommend the selective use of radioactive iodine (RAI) therapy in patients with well differentiated thyroid cancer (WDTC). Despite these… (More)
- Snehal G. Patel, Margarita Escrig, Ashok R. Shaha, Bhuvanesh Singh, Jatin P Shah
- Journal of surgical oncology
- 2002
BACKGROUND AND OBJECTIVE
Well-differentiated thyroid carcinoma (WDTC) is diagnosed in approximately 1.5% of thyroglossal duct cysts (TGDC). No clear consensus exists regarding further management… (More)